Target
exportin-1 (XPO-1)
1 abstract
Abstract
SELISARC: A Spanish Sarcoma Group (GEIS) phase I/II trial of selinexor plus gemcitabine in selected sarcoma subtypes—Results of the phase I part.Org: Fundacion Jimenez Diaz University Hospital, Hospital Clinico San Carlos, Health Research Institute-Fundación Jiménez Díaz University Hospital, Hospital Universitario La Paz - CIBERONC, Hospital U. Miguel Servet,